CIR Circadian Receives $3M R&D Tax Incentive 02/12/15 PRICE SENSITIVE download Created with Sketch. 45.4KB Share CIR Circadian Board Changes and Renewal 30/11/15 PRICE SENSITIVE download Created with Sketch. 258.54KB Share CIR Trading Halt 30/11/15 PRICE SENSITIVE download Created with Sketch. 257.45KB Share CIR Circadian to regain VEGFR-3 intellectual property license 23/10/15 PRICE SENSITIVE download Created with Sketch. 47.36KB Share CIR Appendix 4E and Annual Financial Report 2015 19/08/15 PRICE SENSITIVE download Created with Sketch. 935.84KB Share CIR Circadian Commences Wet AMD OPT-302 Clinical Trial 01/07/15 PRICE SENSITIVE download Created with Sketch. 256.43KB Share CIR Circadian receives IND approval from FDA for Wet AMD Phase 1 15/06/15 PRICE SENSITIVE download Created with Sketch. 257.43KB Share CIR Circadian partner Eli Lilly presents IMC-3C5 Ph1 at ASCO 02/06/15 PRICE SENSITIVE download Created with Sketch. 829.98KB Share CIR Half Year Report and Accounts 26/02/15 PRICE SENSITIVE download Created with Sketch. 571.22KB Share CIR US Patent Granted for Soluble VEGFR-3 Traps 28/01/15 PRICE SENSITIVE download Created with Sketch. 179.31KB Share CIR Circadian Receives $2.2M R&D Tax Incentive 23/01/15 PRICE SENSITIVE download Created with Sketch. 38.07KB Share CIR Circadian Capital Raising Prospectus 09/10/14 PRICE SENSITIVE download Created with Sketch. 386.11KB Share CIR Circadian to Raise A$17.4 Million 06/10/14 PRICE SENSITIVE download Created with Sketch. 210.63KB Share CIR Trading Halt 01/10/14 PRICE SENSITIVE download Created with Sketch. 113.55KB Share CIR Circadian Allowed Key Patent for VEGFR-3 Traps in US 23/09/14 PRICE SENSITIVE download Created with Sketch. 177.09KB Share CIR Preliminary Final Report 29/08/14 PRICE SENSITIVE download Created with Sketch. 263.21KB Share CIR Opthea Awarded Grant for OPT-302 Manufacture 23/06/14 PRICE SENSITIVE download Created with Sketch. 125.98KB Share CIR Opthea Completes Pre-IND Meeting with FDA 12/05/14 PRICE SENSITIVE download Created with Sketch. 130.88KB Share CIR OPT-302 reduces established wet AMD lesions in the mouse 06/05/14 PRICE SENSITIVE download Created with Sketch. 678.8KB Share CIR CEO Terms of Employment 23/04/14 PRICE SENSITIVE download Created with Sketch. 202.72KB Share CIR Half Year Report & Accounts 21/02/14 PRICE SENSITIVE download Created with Sketch. 1.06MB Share CIR Circadian Appoints CEO and Managing Director 21/02/14 PRICE SENSITIVE download Created with Sketch. 260.43KB Share CIR Opthea Signs Cell Line Commercial License Agreement 14/01/14 PRICE SENSITIVE download Created with Sketch. 574.45KB Share CIR Circadian CEO and Board Changes 03/12/13 PRICE SENSITIVE download Created with Sketch. 21.25KB Share CIR Phase 1b oncology trial completed 27/11/13 PRICE SENSITIVE download Created with Sketch. 371.7KB Share CIR R&D Tax Incentive - Circadian To Receive Over $2.5m 15/11/13 PRICE SENSITIVE download Created with Sketch. 51.05KB Share CIR Opthea Signs Manufacturing Agreement 30/10/13 PRICE SENSITIVE download Created with Sketch. 471.6KB Share CIR Phase 1a clinical oncology trial with VGX-100 update 17/10/13 PRICE SENSITIVE download Created with Sketch. 110.33KB Share CIR Open Briefing 28/08/13 PRICE SENSITIVE download Created with Sketch. 288.12KB Share CIR Preliminary Final Report 27/08/13 PRICE SENSITIVE download Created with Sketch. 648.19KB Share CIR FDA GRANTS HUMANITARIAN USE DEVICE DESIGNATION TO VEGF-D KIT 02/07/13 PRICE SENSITIVE download Created with Sketch. 113.7KB Share CIR US patent granted covering use of VEGFR-3 17/06/13 PRICE SENSITIVE download Created with Sketch. 81.39KB Share CIR VGX-100 Phase 1 oncology trial presented at ASCO 2013 04/06/13 PRICE SENSITIVE download Created with Sketch. 1.51MB Share CIR VEGF-C shown to have major role in (AMD) 09/05/13 PRICE SENSITIVE download Created with Sketch. 780.59KB Share CIR VEGF-C shown to have major role in (AMD) 09/05/13 PRICE SENSITIVE download Created with Sketch. 168.95KB Share CIR Circadian grants world-wide licence to Santa Cruz 08/03/13 PRICE SENSITIVE download Created with Sketch. 77.42KB Share CIR CIRCADIAN COMMENCES WORDWIDE MARKETING AND SALES OF REAGENTS 27/02/13 PRICE SENSITIVE download Created with Sketch. 164.79KB Share CIR Half Year Report & Accounts 18/02/13 PRICE SENSITIVE download Created with Sketch. 409.53KB Share CIR R&D Tax Incentive - Circadian Receives $1.3m 07/02/13 PRICE SENSITIVE download Created with Sketch. 26.94KB Share CIR VGX-100 Phase 1 Clinical Trial Program Update 04/02/13 PRICE SENSITIVE download Created with Sketch. 1.08MB Share CIR Licence Grant To Bio-Rad 15/11/12 PRICE SENSITIVE download Created with Sketch. 32.36KB Share CIR VGX-100 Poster Presentation at EORTC 08/11/12 PRICE SENSITIVE download Created with Sketch. 315.62KB Share CIR Preliminary Final Report 23/08/12 PRICE SENSITIVE download Created with Sketch. 1.31MB Share CIR Commercial launch of CUP Test 27/06/12 PRICE SENSITIVE download Created with Sketch. 46.09KB Share CIR Placement 12/06/12 PRICE SENSITIVE download Created with Sketch. 37.49KB Share CIR Reinstatement to Official Quotation 12/06/12 PRICE SENSITIVE download Created with Sketch. 30.35KB Share CIR Suspension From Official Quotation 06/06/12 PRICE SENSITIVE download Created with Sketch. 77.8KB Share CIR Trading Halt 05/06/12 PRICE SENSITIVE download Created with Sketch. 30.43KB Share CIR Healthscope publishes data on CUP Test 09/03/12 PRICE SENSITIVE download Created with Sketch. 273.54KB Share CIR Open Briefing - CEO on H1 Results and Outlook 20/02/12 PRICE SENSITIVE download Created with Sketch. 326.06KB Share CIR Half Yearly Report and Accounts 16/02/12 PRICE SENSITIVE download Created with Sketch. 432.74KB Share CIR VGX-100 potential for improving corneal graft survival 30/01/12 PRICE SENSITIVE download Created with Sketch. 40.29KB Share CIR Circadian commences first Phase 1 clinical trial of VGX-100 09/01/12 PRICE SENSITIVE download Created with Sketch. 32.42KB Share CIR Open Briefing - CEO on IND Status for VGX-100 15/11/11 PRICE SENSITIVE download Created with Sketch. 332.69KB Share CIR FDA approves IND for VGX-100 31/10/11 PRICE SENSITIVE download Created with Sketch. 183.66KB Share CIR Clinical validation study of CUP Test commences 10/10/11 PRICE SENSITIVE download Created with Sketch. 50.18KB Share CIR Circadian files IND with FDA for VGX-100 30/09/11 PRICE SENSITIVE download Created with Sketch. 45.83KB Share CIR Open Briefing - CEO on FY12 Outlook and VGX-100 Progress 15/09/11 PRICE SENSITIVE download Created with Sketch. 366.46KB Share CIR VGX-100 potential new therapy for Dry Eye Disease 13/09/11 PRICE SENSITIVE download Created with Sketch. 41.45KB Share CIR Preliminary Final Report 23/08/11 PRICE SENSITIVE download Created with Sketch. 1.19MB Share CIR Open Briefing - CEO on VGX-100 Clinical Development Plans 14/07/11 PRICE SENSITIVE download Created with Sketch. 313.09KB Share CIR Circadian launches level 1 ADR Program and OTCQX in US 14/06/11 PRICE SENSITIVE download Created with Sketch. 58.59KB Share CIR VEGF-C and VEGF-D Identified as Biomarkers 07/06/11 PRICE SENSITIVE download Created with Sketch. 542.49KB Share CIR Open Briefing - ImClone Phase 1 Trials 07/04/11 PRICE SENSITIVE download Created with Sketch. 343.51KB Share CIR Circadian's VGX-100 Inhibits Tumour Growth in Cancer Models 06/04/11 PRICE SENSITIVE download Created with Sketch. 1.37MB Share CIR Circadian's partner ImClone Systems commences first Phase 1 06/04/11 PRICE SENSITIVE download Created with Sketch. 24.2KB Share CIR Half Yearly Report and Accounts 15/02/11 PRICE SENSITIVE download Created with Sketch. 797.38KB Share CIR CIRCADIAN LAUNCHES FIRST DIAGNOSTIC FOR LAM LUNG DISEASE 02/02/11 PRICE SENSITIVE download Created with Sketch. 30.36KB Share CIR Chugai Worldwide Licence 13/01/11 PRICE SENSITIVE download Created with Sketch. 39.89KB Share CIR Open Briefing - VEGF Patent and Ark Arbitration 18/11/10 PRICE SENSITIVE download Created with Sketch. 344.33KB Share CIR CIRCADIAN AND ARK SETTLE TRINAM ARBITRATION 11/11/10 PRICE SENSITIVE download Created with Sketch. 46KB Share CIR Circadian to be granted significant patents 09/11/10 PRICE SENSITIVE download Created with Sketch. 39.59KB Share CIR Open Briefing - LAM Diagnostic Partnership 14/10/10 PRICE SENSITIVE download Created with Sketch. 277.13KB Share CIR Circadian partners with Cincinnati Childrens Hospital 30/09/10 PRICE SENSITIVE download Created with Sketch. 52.33KB Share CIR CEO on FY11 Outlook and Strategic Focus 09/09/10 PRICE SENSITIVE download Created with Sketch. 394.05KB Share CIR VEGF-D Diagnostics Patent in USA Granted 06/09/10 PRICE SENSITIVE download Created with Sketch. 31.03KB Share CIR Preliminary Final Report 20/08/10 PRICE SENSITIVE download Created with Sketch. 1.3MB Share CIR Open Briefing. CEO on VGX-100 animal tumour model data 04/05/10 PRICE SENSITIVE download Created with Sketch. 392.59KB Share CIR VGX100 signif inhibits tumour growth in animal cancer models 15/04/10 PRICE SENSITIVE download Created with Sketch. 398.03KB Share CIR Half Yearly Report and Accounts 17/02/10 PRICE SENSITIVE download Created with Sketch. 932.85KB Share CIR Circadian and CSIRO enter strategic research alliance 07/12/09 PRICE SENSITIVE download Created with Sketch. 27.56KB Share CIR Circadian subsidiary terminates licence to Ark Therapeutics 29/10/09 PRICE SENSITIVE download Created with Sketch. 38.24KB Share CIR Manufacturing milestone achieved for cancer drug candidate 13/10/09 PRICE SENSITIVE download Created with Sketch. 34.21KB Share CIR CIR provides PerkinElmer rights to market research products 07/09/09 PRICE SENSITIVE download Created with Sketch. 24.99KB Share CIR Circadian granted key VEGF-C patent in Japan 25/08/09 PRICE SENSITIVE download Created with Sketch. 27.53KB Share CIR Preliminary Final Report 20/08/09 PRICE SENSITIVE download Created with Sketch. 1.32MB Share CIR Circadian granted key strategic VEGF-D patent in Europe 18/06/09 PRICE SENSITIVE download Created with Sketch. 35.03KB Share CIR Licensee Ark Therap. - Trinam Ph 3 Trial Enrols 1st Patient 22/05/09 PRICE SENSITIVE download Created with Sketch. 37.94KB Share CIR Open Briefing. CEO on Recent Achievements 19/05/09 PRICE SENSITIVE download Created with Sketch. 268.69KB Share CIR CIR partner ImClone presents positive VEGR-3 AB data at AACR 22/04/09 PRICE SENSITIVE download Created with Sketch. 3.61MB Share CIR Open Briefing on Cancer Diagnostic Commercialisation 02/03/09 PRICE SENSITIVE download Created with Sketch. 285.95KB Share CIR Circadian and Healthscope to commercialise cancer diagnostic 25/02/09 PRICE SENSITIVE download Created with Sketch. 34.4KB Share CIR Half Yearly Report and Accounts 13/02/09 PRICE SENSITIVE download Created with Sketch. 1.06MB Share CIR Open Briefing - CEO on Trinam Phase III Trial 22/01/09 PRICE SENSITIVE download Created with Sketch. 261.88KB Share CIR US FDA clearance received to commence Phase 3 Trinam trial 09/01/09 PRICE SENSITIVE download Created with Sketch. 185.13KB Share
